Center-Authored Papers

Filters: Author is Habermann, Thomas M  [Clear All Filters]
Journal Article
Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD et al..  2015.  Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.. Journal of the National Cancer Institute. 107(12) Abstract
Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Byrd JC, Czuczman MS, Fayad LE et al..  2015.  Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(3):326-62. Abstract
Robinson D, Reynolds M, Casper C, Dispenzieri A, Vermeulen J, Payne K, Schramm J, Ristow K, Desrosiers M-P, Yeomans K et al..  2014.  Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres.. British journal of haematology. Abstract
Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Byrd JC, Fayad LE, Fisher RI et al..  2016.  Diffuse Large B-Cell Lymphoma Version 1.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(2):196-231. Abstract
Gustafson HL, Yao S, Goldman BH, Lee K, Spier CM, Leblanc ML, Rimsza LM, Cerhan JR, Habermann TM, Link BK et al..  2014.  Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.. American journal of hematology. Abstract
Machiela MJ, Lan Q, Slager SL, Vermeulen RCH, Teras LR, Camp NJ, Cerhan JR, Spinelli JJ, Wang SS, Nieters A et al..  2016.  Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes.. Human molecular genetics. 25(8):1663-76. Abstract
Vijai J, Wang Z, Berndt SI, Skibola CF, Slager SL, de Sanjose S, Melbye M, Glimelius B, Bracci PM, Conde L et al..  2015.  A genome-wide association study of marginal zone lymphoma shows association to the HLA region.. Nature communications. 6:5751. Abstract
Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, Hjalgrim H, Kumar V, Chang ET, Rothman N, Cerhan JR et al..  2011.  GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.. PLoS genetics. 7(4):e1001378. Abstract
Habermann TM, Wang SS, Maurer MJ, Morton LM, Lynch CF, Ansell SM, Hartge P, Severson RK, Rothman N, Davis S et al..  2008.  Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.. Blood. 112(7):2694-702. Abstract
Gibson TM, Wang SS, Cerhan JR, Maurer MJ, Hartge P, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK et al..  2012.  Inherited genetic variation and overall survival following follicular lymphoma.. American journal of hematology. 87(7):724-6.
Evens AM, Advani R, Press OW, Lossos IS, Vose JM, Hernandez-Ilizaliturri FJ, Robinson BK, Otis S, Nadav Dagan L, Abdallah R et al..  2013.  Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(32):4132-9. Abstract
Hosein PJ, Maragulia JC, Salzberg MP, Press OW, Habermann TM, Vose JM, Bast M, Advani RH, Tibshirani R, Evens AM et al..  2014.  A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.. British journal of haematology. 165(3):358-63. Abstract
Wierda WG, Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Byrd JC, Caimi P, Fayad LE et al..  2017.  NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.. Journal of the National Comprehensive Cancer Network : JNCCN. 15(3):293-311. Abstract
Horwitz SM, Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Byrd JC, Fayad LE et al..  2016.  NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(9):1067-79. Abstract
Geyer SM, Morton LM, Habermann TM, Allmer C, Davis S, Cozen W, Severson RK, Lynch CF, Wang SS, Maurer MJ et al..  2010.  Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.. Cancer. 116(12):2993-3000. Abstract
Wilson WH, Young RM, Schmitz R, Yang Y, Pittaluga S, Wright G, Lih C-J, Williams MP, Shaffer AL, Gerecitano J et al..  2015.  Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.. Nature medicine. Abstract